MC, S., F, M., P, A., V, B., L, B., S, B., . . . G, R. (2020). Salivary and lacrimal dysfunction after radioactive iodine for differentiated thyroid cancer: American Head and Neck Society Endocrine Surgery Section and Salivary Gland Section joint multidisciplinary clinical consensus statement of otolaryngology, ophthalmology, nuclear medicine and endocrinology. Head & neck, 42(11), 3446. https://doi.org/10.1002/hed.26417
Chicago Style (17th ed.) CitationMC, Singer, et al. "Salivary and Lacrimal Dysfunction After Radioactive Iodine for Differentiated Thyroid Cancer: American Head and Neck Society Endocrine Surgery Section and Salivary Gland Section Joint Multidisciplinary Clinical Consensus Statement of Otolaryngology, Ophthalmology, Nuclear Medicine and Endocrinology." Head & Neck 42, no. 11 (2020): 3446. https://doi.org/10.1002/hed.26417.
MLA (9th ed.) CitationMC, Singer, et al. "Salivary and Lacrimal Dysfunction After Radioactive Iodine for Differentiated Thyroid Cancer: American Head and Neck Society Endocrine Surgery Section and Salivary Gland Section Joint Multidisciplinary Clinical Consensus Statement of Otolaryngology, Ophthalmology, Nuclear Medicine and Endocrinology." Head & Neck, vol. 42, no. 11, 2020, p. 3446, https://doi.org/10.1002/hed.26417.
